Audited Results of Symbiotec Pharmalab Ltd. Company

(Rs in Cr.) Mar 31, 2023
Operating Income 563.59
Manufacturing Expenses 28.75
Personnel Expenses 92.55
Selling Expenses 0.68
Administrative Expenses 58.51
Expenses Capitalised 0
Cost Of Sales 484.12
Operating Profit 79.47
Other Recurring Income 12.37
Adjusted PBDIT 91.83
Financial Expenses 7.42
Depreciation 27.62
Other Write offs 0
Adjusted PBT 56.80
Tax Charges 14.88
Adjusted PAT 41.91
Non Recurring Items -64.28
Other Non Cash adjustments 0
Reported Net Profit -22.66
Equity Dividend 0
Preference Dividend 0
Retained Earnings 500.75

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+
X